Table 1 Sample demographic and clinical characteristics
From: A randomized trial of collaborative support for opioid taper after trauma hospitalization
Characteristic | Intervention group N = 37 | Usual care group N = 36 | Overall cohort N = 73 | |||
|---|---|---|---|---|---|---|
n | % | n | % | n | % | |
Demographics | ||||||
Age, Mean(SD) | 45.4 | 17.3 | 48.2 | 17.6 | 47 | 17.4 |
Male | 26 | 72.2 | 26 | 72.2 | 52 | 72.2 |
Language preference-English | 36 | 97.3 | 36 | 100 | 72 | 98.6 |
Race | ||||||
White | 35 | 94.6 | 31 | 86.1 | 66 | 90.4 |
African American | 2 | 5.4 | 1 | 2.8 | 3 | 4.1 |
American Indian | 0 | 0 | 2 | 5.6 | 2 | 2.7 |
Pacific Islander | 0 | 0 | 2 | 5.6 | 2 | 2.7 |
Hispanic | 1 | 2.7 | 2 | 5.6 | 3 | 4.1 |
Residence location* | ||||||
Urban | 21 | 58.3 | 28 | 77.8 | 49 | 68.1 |
Large Rural Town | 10 | 27.8 | 5 | 13.9 | 15 | 20.8 |
Small Rural Town | 4 | 11.1 | 1 | 2.8 | 5 | 6.9 |
Isolated Small Rural Town | 1 | 2.8 | 2 | 5.6 | 3 | 4.2 |
Injury descriptors | ||||||
Injury Severity Score, Mean(SD) | 13 | 8.5 | 13.5 | 8 | 13.2 | 8.2 |
Inpatient pain management strategies | ||||||
Total opioid days, Mean(SD) | 5.1 | 3.2 | 5.7 | 3.6 | 5.4 | 3.3 |
Total IV opioid days, Mean(SD) | 0.4 | 0.7 | 0.6 | 1.6 | 0.5 | 1.2 |
Total oral opioid days, Mean(SD) | 4.7 | 3 | 5.1 | 3.1 | 4.9 | 3 |
Substance use disorder testing | ||||||
Admission alcohol testing | ||||||
Not tested | 6 | 16.2 | 9 | 25 | 15 | 20.6 |
Neg | 28 | 75.7 | 20 | 55.6 | 48 | 65.8 |
Yes(1-79mg/dl) | 2 | 5.4 | 3 | 8.3 | 5 | 6.9 |
Yes(80mg/dl or higher) | 1 | 2.7 | 4 | 11.1 | 5 | 6.9 |
Admission urine toxicology screening | ||||||
Not tested | 25 | 67.6 | 20 | 55.6 | 45 | 61.6 |
Neg | 6 | 16.2 | 9 | 25 | 15 | 20.6 |
Pos | 6 | 16.2 | 7 | 19.4 | 13 | 17.8 |
Amphetamine/Methamphetamine | 2 | 5.4 | 2 | 5.6 | 4 | 5.5 |
Cocaine | 0 | 0 | 1 | 2.8 | 1 | 1.4 |
Cannabis | 4 | 10.8 | 6 | 16.7 | 10 | 13.7 |
Inpatient stay characteristics | ||||||
Total Hospital Days, Mean (SD) | 4.5 | 3.4 | 5 | 3.8 | 4.7 | 3.6 |
Opioid daily dose at hospital discharge, MED Mean(SD) | 75.3 | 28 | 66.7 | 25.2 | 71 | 26.8 |
Pre-trauma pain, opioid, drug use | ||||||
Chronic pain for the last 3 months pre-trauma | 15 | 40.5 | 11 | 32.4 | 26 | 36.6 |
Lifetime Opioid exposure | 28 | 75.7 | 26 | 76.5 | 54 | 76.1 |
Opioid exposure (N) during pre-trauma month (from WA PDMP) | 3 | 8.3 | 4 | 11.1 | 7 | 9.7 |
Opioid dose (mean MED) during pre-trauma month (from WA PDMP) | 1.8 | 6.3 | 5.3 | 18.3 | 3.5 | 13.7 |
Lifetime Cannabis (# times used) | ||||||
0 | 10 | 27 | 10 | 29.4 | 20 | 28.2 |
1–2 | 5 | 13.5 | 2 | 5.9 | 7 | 9.9 |
3–5 | 1 | 2.7 | 2 | 5.9 | 3 | 4.2 |
10–19 | 2 | 5.4 | 6 | 17.7 | 8 | 11.3 |
20–39 | 2 | 5.4 | 2 | 5.9 | 4 | 5.6 |
40 or more | 17 | 46 | 12 | 35.3 | 29 | 40.9 |
Use of any drug other than required for medical reason in 12 months prior to trauma | 1 | 2.7 | 2 | 5.7 | 3 | 4.2 |